BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Van Der Steen N, Deben C, Deschoolmeester V, Wouters A, Lardon F, Rolfo C, Germonpré P, Giovannetti E, Peters GJ, Pauwels P. Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer. World J Clin Oncol 2016; 7(6): 425-432 [PMID: 28008383 DOI: 10.5306/wjco.v7.i6.425]
URL: https://www.wjgnet.com/2218-4333/full/v7/i6/425.htm
(329) (386) (0) (0) (6449) (8)
Number Citing Articles
1
Somayeh Nazari, Fatemeh Mosaffa, Alireza Poustforoosh, Motahareh Mortazavi, Luciano Saso, Omidreza Firuzi, Fatemeh Moosavi. Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters. Toxicology and Applied Pharmacology 2024; 484 doi: 10.1016/j.taap.2024.116866
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.